Indications and uses
helps prevent sunburn. if used as directed with other sun protection measures (see Directions ), helps decrease the risk of skin cancer and early skin aging caused by the sun.
helps prevent sunburn. if used as directed with other sun protection measures (see Directions ), helps decrease the risk of skin cancer and early skin aging caused by the sun.
apply liberally 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To help decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: – limit time in the sun, especial...
Protect this product from excessive heat and direct sun
Drug Facts
Octinoxate 4.5%,
Zinc Oxide 9.5%
Sunscreen
For external use only
Keep out of reach of children.
Water/Aqua, Caprylic/Capric Triglyceride, Dimethicone, Dimethyl Isosorbide, Methyl Gluceth-20, Glyceryl Stearate, PEG-100 Stearate, Stearic Acid, Cetearyl Alcohol, Hydrolyzed Pearl, Juglans Regia (Walnut) Seed Extract, Sodium Hyaluronate Crosspolymer, Silanetriol, Lavandula Spica (Lavender) Flower Oil, Lavandula Hybrida Oil, Eucalyptus Globulus Leaf Oil, Lavandula Angustifolia (Lavender) Flower/Leaf/Stem Extract, Hydroxyethyl Acrylate/ Sodium Acryloyldimethyl Taurate Copolmer, Polyhydroxystearic Acid, Squalane, Triethoxycaprylylsilane, Polysorbate 60, Cetyl Alcohol, Silica Dimethyl Silylate, Magnesium Aluminum Silicate, Pentylene Glycol, Ethylhexylglycerin, Disodium EDTA, Silica, Phenoxyethanol, Tin Oxide, Iron Oxides (CI 77491, CI 77492, CI 77499), Titanium Dioxide (CI 77891).
1-800-831-5150 in USA
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68479-201-00 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-201-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-301-00 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-301-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-901-00 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-901-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| 68479-901-04 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-55a6-a910-e053-dadaa90a0b85 | Sheer Tint SPF20 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68479-201-00 | Sheer Tint SPF20 - Light | 2 mL in 1 POUCH | LOTION | 2 | 3 | |
| 68479-201-02 | Sheer Tint SPF20 - Light | 40 mL in 1 TUBE | LOTION | 40 | 3 | |
| 68479-201-02 | Sheer Tint SPF20 - Light | 1 in 1 CARTON | LOTION | 1 | 3 | |
| 68479-301-00 | Sheer Tint SPF20 - Dark | 2 mL in 1 POUCH | LOTION | 2 | 3 | |
| 68479-301-02 | Sheer Tint SPF20 - Dark | 40 mL in 1 TUBE | LOTION | 40 | 3 | |
| 68479-301-02 | Sheer Tint SPF20 - Dark | 1 in 1 CARTON | LOTION | 1 | 3 | |
| 68479-901-00 | Sheer Tint SPF20 - Medium | 2 mL in 1 POUCH | LOTION | 2 | 3 | |
| 68479-901-02 | Sheer Tint SPF20 - Medium | 40 mL in 1 TUBE | LOTION | 40 | 3 | |
| 68479-901-02 | Sheer Tint SPF20 - Medium | 1 in 1 CARTON | LOTION | 1 | 3 | |
| 68479-901-04 | Sheer Tint SPF20 - Medium | 118 mL in 1 BOTTLE, PLASTIC | LOTION | 118 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68479-201 | SHEER TINT SPF20 - LIGHT (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - MEDIUM (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - DARK (ZINC OXIDE AND OCTINOXATE) LOTION [DERMALOGICA, INC.] | 3 | Legacy NDC, 3 package rows | 20171205_75672423-b04a-46d8-9b43-50742d4a58f4.zip |
| 68479-301 | SHEER TINT SPF20 - LIGHT (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - MEDIUM (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - DARK (ZINC OXIDE AND OCTINOXATE) LOTION [DERMALOGICA, INC.] | 3 | Legacy NDC, 3 package rows | 20171205_75672423-b04a-46d8-9b43-50742d4a58f4.zip |
| 68479-901 | SHEER TINT SPF20 - LIGHT (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - MEDIUM (ZINC OXIDE AND OCTINOXATE) LOTION SHEER TINT SPF20 - DARK (ZINC OXIDE AND OCTINOXATE) LOTION [DERMALOGICA, INC.] | 3 | Legacy NDC, 4 package rows | 20171205_75672423-b04a-46d8-9b43-50742d4a58f4.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 2 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 2 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 2 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 2 | |
| Calcium Carbonate | INACTIVE INGREDIENT | H0G9379FGK | 2 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 2 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Dimethyl Isosorbide | INACTIVE INGREDIENT | SA6A6V432S | 2 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| English Walnut | INACTIVE INGREDIENT | 1V3SHR7QB7 | 2 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 2 | |
| Eucalyptus Oil | INACTIVE INGREDIENT | 2R04ONI662 | 2 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| Ferrosoferric Oxide | INACTIVE INGREDIENT | XM0M87F357 | 2 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 2 | |
| Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer (100000 MPA.S at 1.5%) | INACTIVE INGREDIENT | 86FQE96TZ4 | 2 | |
| Lavandin Oil | INACTIVE INGREDIENT | 9RES347CKG | 2 | |
| Lavandula Angustifolia Flowering Top | INACTIVE INGREDIENT | 9YT4B71U8P | 2 | |
| Lavender Oil | INACTIVE INGREDIENT | ZBP1YXW0H8 | 2 | |
| Magnesium Aluminum Silicate | INACTIVE INGREDIENT | 6M3P64V0NC | 2 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 2 | |
| Methyl Gluceth-20 | INACTIVE INGREDIENT | J3QD0LD11P | 2 | |
| PEG-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 2 | |
| PEG-9 Diglycidyl Ether/Sodium Hyaluronate Crosspolymer | INACTIVE INGREDIENT | 788QAG3W8A | 2 | |
| Pentylene Glycol | INACTIVE INGREDIENT | 50C1307PZG | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Polyhydroxystearic Acid (2300 MW) | INACTIVE INGREDIENT | YXH47AOU0F | 2 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 2 | |
| Silanetriol | INACTIVE INGREDIENT | E52D0J3TS5 | 2 | |
| Silica Dimethyl Silylate | INACTIVE INGREDIENT | EU2PSP0G0W | 2 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| Squalane | INACTIVE INGREDIENT | GW89575KF9 | 2 | |
| Stannic Oxide | INACTIVE INGREDIENT | KM7N50LOS6 | 2 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68479-201 | 68479-201-02, 68479-201-00 |
| 68479-901 | 68479-901-02, 68479-901-04, 68479-901-00 |
| 68479-301 | 68479-301-02, 68479-301-00 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / RECTAL | 0.05 mg/mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / IONTOPHORESIS | 0.1 mg | ||
| Magnesium Aluminum Silicate | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | LIQUID / ORAL | 82 mg/5ml | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | FILM / BUCCAL | 0.27 mg | ||
| PEG-100 Stearate | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| Dimethyl Isosorbide | DIMETHYL ISOSORBIDE | SA6A6V432S | AEROSOL, FOAM / TOPICAL | 5.44 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET / ORAL | 793 mg | ||
| Magnesium Aluminum Silicate | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | CREAM / TOPICAL | 3 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / BUCCAL | 0.4 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Squalane | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| PEG-100 Stearate | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| Magnesium Aluminum Silicate | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | SYRUP / ORAL | 100 mg/1ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Magnesium Aluminum Silicate | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | LOTION / TOPICAL | 1.5 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED PELLETS / ORAL | 4.4 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / INTRAVENOUS | 4.02 %w/v | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, COATED / ORAL | 64.8 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| Lavender Oil | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | CREAM / TOPICAL | 225 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | POWDER, FOR SUSPENSION / ORAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | GUM, CHEWING / BUCCAL | 5 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4a5b3b50-dc18-4662-be96-2c8abb99870e | 75672423-b04a-46d8-9b43-50742d4a58f4 | 2017-12-04 | Warnings | 4a5b3b50-dc18-4662-be96-2c8abb99870e 75672423-b04a-46d8-9b43-50742d4a58f4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.